Decision reversed: Medicare will not pay for OPT in occult wet AMD

Article

Washington, DC-Citing concerns about safety and long-term benefits, the U.S. Centers for Medicare and Medicaid Services (CMS) has reversed its October 2001 decision to reimburse patients who receive ocular photodynamic therapy (PCT)

Related Videos
This series features 1 KOL.
This series features 1 KOL.
This series features 1 KOL.
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
© 2024 MJH Life Sciences

All rights reserved.